Testimony focused on challenges in addressing counternarcotics issues, obstacles to the implementation of U.S. drug control efforts, and areas requiring attention to improve the operational effectiveness of international drug control activities. The official noted illegal drugs still flood the United States despite longstanding efforts and large expenditures, the United States and drug production and transit countries face several obstacles in attempting to reduce the production of and trafficking in illegal drugs, and the United States has not been able to maintain a well-organized and consistently funded international counternarcotics program. The official also indicated some countries have taken steps to improve their capacity to reduce the flow of illegal drugs into the United States, to extradite drug criminals, to control organized crime and money laundering, to control chemicals used in the production of illicit drugs, and to reduce corruption. He recommends the Office of National Drug Control Policy develop a multiyear plan that includes performance measures and long-term funding needs linked to goals and objectives of the international drug control strategy. A list of related products published by the U.S. General Accounting Office is included.